Concepedia

Chengfei Hao

CH

Statistics

Publications

5

Citations

84

H-Index

5

Active since

2015

Affiliations

Tianjin Nankai Hospital(Current)

Tianjin Hospital

Tianjin Medical University

Chengfei Hao is an author at Tianjin Nankai Hospital specializing in medicine, oncology, and molecular oncology.

Publications per year

2015–2022

5

Publications

5

Carboxypeptidase A4 promotes proliferation and stem cell characteristics of hepatocellular carcinoma

Hongtao Zhang, Chengfei Hao, Haibo Wang et al. · International Journal of Experimental Pathology · 2019 · 23 citations · Full text

, , +16

The mechanism of Yinchenhao decoction in treating obstructive-jaundice-induced liver injury based on Nrf2 signaling pathway

Junjian Liu, Yan Xu, Shuai Chen et al. · World Journal of Gastroenterology · 2022 · 19 citations · Full text

, , +17

CSN5 silencing reverses sorafenib resistance of human hepatocellular carcinoma HepG2 cells

Haibo Wang, Zhengyao Qian, Hui Zhao et al. · Molecular Medicine Reports · 2015 · 18 citations · Full text

, , +16

Sugiol (127horbar;hydroxyabieta-8,11,13-trien-7-one) targets human pancreatic carcinoma cells (Mia-PaCa2) by inducing apoptosis, G2/M cell cycle arrest, ROS production and inhibition of cancer cell migration.

Chengfei Hao, Xibo Zhang, Hongtao Zhang et al. · PubMed · 2019 · 14 citations

, , +17

The choice of operation timing of laparoscopic cholecystectomy (LC) after percutaneous transhepatic gallbladder drainage (PTGBD) for acute cholecystitis: a retrospective clinical analysis

Jianheng Bao, Jianxiong Wang, Hai-Tao Shang et al. · Annals of Palliative Medicine · 2021 · 10 citations · Full text

, , +15

1–5 of 5